12. February 2021
Cannovum is now part of the BPC
We are excited to announce our partnership with the BPC, who promote sustainable development of cannabinoid therapies and strengthen the legitimacy of the pharmaceutical cannabinoid industry.
05. January 2021
Handelsblatt: Interview with our CEO Pia Marten
Handelsblatt published an entrepreneur profile that covers the motivation of our CEO Pia Marten behind founding Cannovum AG.
Find the article here:
08. December 2020
Market entry Cannovum
With the market entry and the launch of our online shop, Cannovum takes a big step forward to further improve the supply of patients with cannabinoid-based therapies.
03. November 2020
Cannovum welcomes Sanda Bütow as Head of Medical Affairs.
Sandra has 15 years of experience in the healthcare industry and has led the development of the medical affairs department and the education platform "Aurora Academy" for the Canadian manufacturer Aurora.
17. October 2020
Meeting in Berlin with Friedrich Merz (Politician/CDU)
Our CEO Pia Marten met Friedrich Merz and other entrepreneurs in Berlin. The discussion focused on topics like digitalization, entrepreneurship, and promotion of innovation.
12. October 2020
Cannovum received its GMP manufacturing license
Cannovum is now a fully licensed pharmaceutical wholesaler and manufacturer. This means we can streamline our supply chain by packaging and labeling in Germany.
10. August 2020
Chief Medical Advisor
We are pleased to announce that Dr. med. Dipl.-Chem. Konrad F. Cimander will support us with his expertise in the field of medical cannabis. Learn more about Dr. Cimander on our Medical Advisory Board:
30. July 2020
Fully licensed wholesaler
We are now a fully licensed pharmaceutical wholesaler and ready to make our vision come true! Find our licenses here:
21. July 2020
Moved to Factory Berlin
Cannovum AG has moved to Factory Berlin. We are looking forward to meeting many more innovative companies and expanding our network.
24. June 2020
Cultivator successfully audited
Cannovum performed a successful GMP audit of its first supplier. We ensure that our cultivators adhere to strict EU GMP regulations, highest standards and quality.
22. May 2020
Who is the typical German cannabis patient? (English article)
Pia has released an english translation of her well received Krautinvest.de article. Read about her insights from the BfArM survey on Medium:
03. May 2020
Who is the typical German cannabis patient? (German article)
Our CEO and Co-Founder has studied the most comprehensive data on cannabis patients in Germany and shared her insights on Krautinvest.de:
24. April 2020
Cannovum received the GDP certificate
And another one: We're now officially compliant to EU-GDP standards. See our licenses below:
24. April 2020
Cannovum received the pharmaceutical wholesale license
Cannovum reached another milestone! We were granted the pharmaceutical wholesale license (§52a AMG). See our license below:
15. March 2020
Cannovum is an official supporting member of the BvCW
We're happy to be part of the network that connects the cannabis industry in Germany and Europe! Learn more about the BvCW on their website:
10. March 2020
Cannovum is now a member of the VCA
We're proud to announce that we're now an official supporting member of the "VCA", the German association for cannabis dispensing pharmacies.
Copyright CANNOVUM AG © 2021
Rheinsberger Str. 76/77